What's Going On With BioRestorative Therapies Stock?

Zinger Key Points
  • BioRestorative Therapies reports a net loss for the first quarter of $2.2 million, or 33 cents per share.
  • The company also reports it ended the first quarter with cash, cash equivalents, and investments held in marketable securities of $16.4M.

BioRestorative Therapies, Inc. BRTX shares are trading higher Monday after the company announced it has received notice from the Nasdaq Stock Market that it has regained compliance with listing requirements. 

The Details:

BioRestorative Therapies reported a net loss for the first quarter of $2.2 million, or 33 cents per share, compared to a net loss of $7.2 million, or $1.93 per share, from the same period last year. The company reported a loss from operations of $4.1 million, a 29% improvement from the $5.8 million loss from operations for the comparable period of 2023. 

The company also reported it ended the first quarter with cash, cash equivalents, and investments held in marketable securities of $16.4 million. 

BioRestorative Therapies shares are moving on heavy trading volume Monday following the announcement. According to data from Benzinga Pro, more than 3 million shares have been traded in the session, compared to the stock’s 100-day average of 2.014 million shares.

Related News: What’s Going On With Carnival’s Stock?

How To Buy BRTX Stock:

By now you're likely curious about how to participate in the market for BioRestorative Therapies – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of BioRestorative Therapies which is trading at $2.23 as of publishing time, $100 would buy you 44.84 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

BRTX Price Action: According to Benzinga Pro, BioRestorative Therapies shares are up 18.4% at $2.19 at the time of publication Monday.

Image: PublicDomainPictures from Pixabay

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!